rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
21
|
pubmed:dateCreated |
2001-11-7
|
pubmed:abstractText |
In women with a family history of breast cancer, bilateral prophylactic mastectomy is associated with a decreased risk of subsequent breast cancer of approximately 90%. We examined the association between bilateral prophylactic mastectomy and breast cancer risk in women at high risk for breast cancer who also had mutations in BRCA1 and BRCA2 genes.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0027-8874
|
pubmed:author |
pubmed-author:CouchF JFJ,
pubmed-author:DeffenbaughAA,
pubmed-author:DonohueJ HJH,
pubmed-author:FrankT STS,
pubmed-author:FrostM HMH,
pubmed-author:GrantC SCS,
pubmed-author:HartmannL CLC,
pubmed-author:JenkinsR BRB,
pubmed-author:McDonnellS KSK,
pubmed-author:SchaidD JDJ,
pubmed-author:SellersT ATA,
pubmed-author:SittaD LDL,
pubmed-author:SoderbergC LCL,
pubmed-author:VockleyC WCW,
pubmed-author:WoodsJ EJE
|
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
93
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1633-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11698567-Breast Neoplasms,
pubmed-meshheading:11698567-Female,
pubmed-meshheading:11698567-Genes, BRCA1,
pubmed-meshheading:11698567-Genes, BRCA2,
pubmed-meshheading:11698567-Heterozygote,
pubmed-meshheading:11698567-Humans,
pubmed-meshheading:11698567-Incidence,
pubmed-meshheading:11698567-Mastectomy,
pubmed-meshheading:11698567-Mutation
|
pubmed:year |
2001
|
pubmed:articleTitle |
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
|
pubmed:affiliation |
Division of Medical Oncology, Mayo Clinic and Foundation, Rochester, MN 55905, USA. hartmann.lynn@mayo.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|